Location
United States, North America
Check Size
$500K - $15M
Investment Stage
Seed
Series A
Focus Areas
Health IT
Health & Hospital Services
BioTech
Enterprise
Manufacturing
Pharmaceuticals
About Investor
Guillaume Pfefer is CEO Partner at Flagship Pioneering in Cambridge, deploying $500K–$15M into seed and Series A pharmaceuticals, biotech, manufacturing, health IT, and enterprise ventures. His most recent investment is Senda Biosciences via Flagship, now part of Sail Biomedicines. He formerly led global vaccine strategy at GSK (including Shingrix), has 25 years in biotech, and now steers Flagship’s incubator-model innovation.
Previous investments
Senda Biosciences
120M |2022
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,JR
JJ Richa
United States, North America
$50K - $1M
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP